tiprankstipranks
Tenaya Therapeutics (TNYA)
NASDAQ:TNYA
US Market

Tenaya Therapeutics (TNYA) Income Statement

Compare
1,945 Followers

Tenaya Therapeutics Income Statement

Last quarter (Q4 2024), Tenaya Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Tenaya Therapeutics's net income was $-23.84M. See Tenaya Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -8.69M$ -8.71M$ -4.03M$ -2.48M
Operating Expenses
$ 115.95M$ 131.19M$ 125.62M$ 72.81M$ 38.91M
Depreciation and Amortization
$ 0.00$ 8.69M$ 8.71M$ 4.03M$ 2.48M
EBITDA
$ -115.95M$ -122.51M$ -114.95M$ -68.70M$ -36.43M
Operating Income
$ -115.95M$ -131.19M$ -125.62M$ -72.81M$ -38.91M
Other Income/Expenses
$ 4.82M$ 7.11M$ 1.96M$ 85.00K$ 517.00K
Pretax Income
$ -111.13M$ -124.08M$ -123.67M$ -72.72M$ -38.40M
Net Income
$ -111.13M$ -124.08M$ -123.66M$ -69.65M$ -38.31M
Per Share Metrics
Basic EPS
$ -1.31$ -1.68$ -2.76$ -1.69$ -0.93
Diluted EPS
$ -1.31$ -1.68$ -2.76$ -1.69$ -0.93
Weighted Average Shares Outstanding
84.82M 73.79M 44.82M 41.29M 41.12M
Weighted Average Shares Outstanding (Diluted)
84.82M 73.79M 44.82M 41.29M 41.12M
Currency in USD

Tenaya Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis